Notch Signaling in Developmental and Tumor Angiogenesis
Open accessThe DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Abstract
The discovery that Notch, a key regulator of cell fate determination, is functional in the vasculature has greatly improved our understanding of differentiation and specialization of vessels. Notch signaling has been proven to be critical for arterial specification, sprouting angiogenesis, and vessel maturation. In newly forming vascular sprouts, Notch promotes the distinction between the leading "tip" endothelial cell and the growing "stalk" cell, the endothelial cells that eventually form a new capillary. Notch signaling has also been implicated in vessel stability by regulating vascular mural cell function. More recently, macrophages carrying an activated Notch have been implicated in shaping the course of new sprout formation. Tumor vessels abide by similar principles and use Notch signaling in similar ways. An exciting discovery, made by several researchers, shows that blocking Notch function in tumor vasculature provides a means by which to suppress tumor growth. The authors discuss the developmental and physiological role of Notch in the vasculature and apply this knowledge to an overview of how Notch targeting in the tumor environment can affect tumor angiogenesis and growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notch signaling plays a key role in determining cell fate and regulating embryonic as well as tumor angiogenesis [132, 133].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986 · cited 1×
“Several studies demonstrate that VEGF-A is overexpressed in many human tumors.(93) Therefore, it is not surprising that inhibition of angiogenesis and development of the VEGF blockade have been considered an attractive strategy to treat human cancer (Table 1).”
BackgroundSorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060655 · Cited by 4,802
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Kopan, R., & Ilagan, M. X. G. (2009) · Cell · doi:10.1016/j.cell.2009.03.045 · Cited by 3,643 · cited 1×
“At the cell surface, Notch is presented as an extracellular and intracellular heterodimeric receptor held together by noncovalent bonds.(3) Ligand binding to the extracellular peptide alters the receptor confirmation, leading to 2 proteolytic cleavages.”
BackgroundHeterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287 · cited 1×
“To describe the diversity of their activation states and function, a simplified paradigm of macrophage polarization toward an M1 “classic” or M2 “alternative” activation state is useful.(71) M1 macrophages are induced in response to lipopolysaccharide (LPS) and interferon-gamma (IFN-γ) and produce inducible nitric oxi…”
BackgroundVEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302047 · Cited by 2,894
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Sternberg, C. N., Davis, I. D., Mardiak, J., Szczylik, C., Lee, E., Wagstaff, J., Barrios, C. H., Salman, P., Gladkov, O. A., Kavina, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.9764 · Cited by 2,471
Inflammation in Wound Repair: Molecular and Cellular Mechanisms
Eming, S. A., Krieg, T., & Davidson, J. M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700701 · Cited by 2,429 · cited 1×
“Wounds, tumors, and many other pathological processes are characterized by increased expression of VEGF that acts as a chemoattractant for inflammatory cells.(37,91) Notch-regulated VEGFR-1 expression may also mediate macrophage function at these sites.”
BackgroundPegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Mendel, D. B., Laird, A., Xin, X., Louie, S. G., Christensen, J. G., Li, G., Schreck, R., Abrams, T. J., Ngai, T. J., Lee, L. B., et al. (2003) · PubMed · Cited by 2,157
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068 · cited 1×
“Mutations in the human NOTCH3 gene are associated with the adult-onset stroke disease, CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), which is caused by cerebral vessel instability due to a loss of arterial vSMC coverage.(59) The late onset of CADASIL and the dela…”
BackgroundEndothelial/Pericyte Interactions
Armulik, A., Abramsson, A., & Betsholtz, C. (2005) · Circulation Research · doi:10.1161/01.res.0000182903.16652.d7 · Cited by 2,048 · cited 1×
“In addition, unlike vSMCs, which are exclusively found outside the endothelial basement membrane, pericytes share a basement membrane with the endothelium through which they can make direct contact with endothelial cells.(51) The intimate association of mural cells and endothelial cells provides an opportunity for Not…”
BackgroundDll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A.-K., Karlsson, L., Gaiano, N., et al. (2007) · Nature · doi:10.1038/nature05571 · Cited by 1,775 · cited 4×
“Gene disruption of Dll4 led to supernumerous angiogenic sprouts, resulting in increased retinal vascular density.(21,38,42,43) This Dll4 mutant phenotype correlated with an expansion of the expression of the tip cell markers, Vegfr-2, Vegfr-3, and Pdgfb, at the vascular front.”
BackgroundResultInfluentialBatchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691
Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621
Presta, L. G., Chen, H., O'Connor, S. J., Chisholm, V., Meng, Y. G., KRUMMEN, L. A., Winkler, M., & Ferrara, N. (1997) · PubMed · Cited by 1,608
Miller, K. D., Chap, L. I., Holmes, F. A., Cobleigh, M. A., Marcom, P. K., Fehrenbacher, L., Dickler, M., Overmoyer, B. A., Reimann, J. D., Sing, A. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.098 · Cited by 1,306
Benjamin, L. E., Hemo, I., & Keshet, E. (1998) · Development · doi:10.1242/dev.125.9.1591 · Cited by 1,265
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., & Nuseir, N. (1987) · Nature · doi:10.1038/329630a0 · Cited by 1,210
Fantin, A., Vieira, J. M., Gestri, G., Denti, L., Schwarz, Q., Prykhozhij, S., Peri, F., Wilson, S. W., & Ruhrberg, C. (2010) · Blood · doi:10.1182/blood-2009-12-257832 · Cited by 1,153
Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities.
Levéen, P., Pekny, M., Gebre-Medhin, S., Swolin, B., Larsson, E., & Betsholtz, C. (1994) · Genes & Development · doi:10.1101/gad.8.16.1875 · Cited by 1,131 · cited 1×
“Pdgfrb is knocked out display decreased vascular mural cell coverage that caused dilation and hemorrhaging of vessels, ultimately resulting in perinatal death.(60,61) Interestingly, PDGFR-β has been shown to be a direct gene target of Notch.”
BackgroundSunderkötter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R., & Sorg, C. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.55.3.410 · Cited by 1,120
The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
Benedito, R., Roca, C., Sörensen, I., Adams, S., Gossler, A., Fruttiger, M., & Adams, R. H. (2009) · Cell · doi:10.1016/j.cell.2009.03.025 · Cited by 1,107 · cited 2×
“In contrast, the Adams group has shown that loss of endothelial Jagged1 results in a decrease in retinal vascular density, suppression of the tip cell phenotype, and an increase in Vegfr-2 expression.(45) From these data, it has been proposed that Jagged1 functions to inhibit Dll4/Notch1 between neighboring endothelia…”
BackgroundNotch signaling is essential for vascular morphogenesis in mice
Krebs, L. T., Xue, Y., Norton, C. R., Shutter, J. R., Maguire, M., Sundberg, J. P., Gallahan, D., Closson, V., Kitajewski, J., Callahan, R., et al. (2000) · Genes & Development · doi:10.1101/gad.14.11.1343 · Cited by 1,060
Cursiefen, C., Chen, L., Borges, L. P., Jackson, D. G., Cao, J., Radziejewski, C. H., D'Amore, P. A., Dana, M. R., Wiegand, S. J., & Streilein, J. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420465 · Cited by 1,059 · cited 1×
“It has also been proposed that VEGF stimulates inflammatory lymphangiogenesis via recruitment and function of macrophages.(83) In addition to VEGF, there is increasing evidence that Ang2, via Tie2 expressed on macrophages, plays an important role in their proangiogenic activity, particularly in tumor models.”
BackgroundLessons from phase III clinical trials on anti-VEGF therapy for cancer
Jain, R. K., Duda, D. G., Clark, J. W., & Loeffler, J. S. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0403 · Cited by 1,039 · cited 1×
“VEGF inhibitors, including Food and Drug Administration (FDA)–approved bevacizumab (Avastin), have been shown to reduce tumor angiogenesis and tumor growth and are now validated for cancer therapy.(94) However, different tumors reportedly exhibit widely varying susceptibility to VEGF inhibition.”
BackgroundBlockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Chieh Lin, H., Yancopoulos, G. D., & Thurston, G. (2006) · Nature · doi:10.1038/nature05355 · Cited by 1,032
Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice.
Soriano, P. (1994) · Genes & Development · doi:10.1101/gad.8.16.1888 · Cited by 989
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
Ridgway, J., Zhang, G., Wu, Y., Stawicki, S., Liang, W.-C., Chanthery, Y., Kowalski, J., Watts, R. J., Callahan, C., Kasman, I., et al. (2006) · Nature · doi:10.1038/nature05313 · Cited by 986
Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting
Jakobsson, L., Franco, C. A., Bentley, K., Collins, R. T., Ponsioen, B., Aspalter, I. M., Rosewell, I., Busse, M., Thurston, G., Medvinsky, A., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2103 · Cited by 971 · cited 1×
“Using computational modeling and sprouting assays with genetically mosaic cells, the Gerhardt group found that endothelial cells are in constant competition for the tip cell position at the leading edge of an angiogenic front.(48) They propose that endothelial tip cell identity is transitory and dependent on environme…”
MethodHiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
FERRARA, N., DAMICO, L., SHAMS, N., LOWMAN, H., & KIM, R. (2006) · Retina · doi:10.1097/01.iae.0000242842.14624.e7 · Cited by 849
Notch signalling in solid tumours: a little bit of everything but not all the time
Ranganathan, P., Weaver, K. L., & Capobianco, A. J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3035 · Cited by 824 · cited 1×
“A role for Notch signaling is well documented in both hematological malignancies and solid tumors.(95) Notch has been demonstrated to act as either a tumor suppressor or an oncogene in a contextdependent manner.”
BackgroundBlocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
Tammela, T., Zarkada, G., Wallgard, E., Murtomäki, A., Suchting, S., Wirzenius, M., Waltari, M., Hellström, M., Schomber, T., Peltonen, R., et al. (2008) · Nature · doi:10.1038/nature07083 · Cited by 813 · cited 3×
“In retinal angiogenesis, it has become clear that proper levels and localization of VEGFR-1, VEGFR-2, and VEGFR-3 are critical for tip cell identity and function.(38,44) Inhibition of Vefgr-2 signaling in the retina results in decreased vessel density characterized by a reduction in endothelial cells with filopodia, s…”
BackgroundSuchting, S., Freitas, C., le Noble, F., Benedito, R., Bréant, C., Duarte, A., & Eichmann, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611177104 · Cited by 811 · cited 3×
“Notch indirectly inhibits VEGFR-2 expression via Hey2 induction,(28) whereas Notch activation induces VEGFR-1 transcripts and protein levels.(21,29-31) However, it is not clear whether VEGFR-1 induction”
BackgroundHirschi, K. K., Rohovsky, S. A., & D'Amore, P. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.3.805 · Cited by 796
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
Fischer, C., Jonckx, B., Mazzone, M., Zacchigna, S., Loges, S., Pattarini, L., Chorianopoulos, E., Liesenborghs, L., Koch, M., De Mol, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.038 · Cited by 779
Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting
Lobov, I. B., Renard, R. A., Papadopoulos, N., Gale, N. W., Thurston, G., Yancopoulos, G. D., & Wiegand, S. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611206104 · Cited by 774 · cited 2×
“Gene disruption of Dll4 led to supernumerous angiogenic sprouts, resulting in increased retinal vascular density.(21,38,42,43) This Dll4 mutant phenotype correlated with an expansion of the expression of the tip cell markers, Vegfr-2, Vegfr-3, and Pdgfb, at the vascular front.”
BackgroundDirect inhibition of the NOTCH transcription factor complex
Moellering, R. E., Cornejo, M., Davis, T. N., Bianco, C. D., Aster, J. C., Blacklow, S. C., Kung, A. L., Gilliland, D. G., Verdine, G. L., & Bradner, J. E. (2009) · Nature · doi:10.1038/nature08543 · Cited by 752
Therapeutic antibody targeting of individual Notch receptors
Wu, Y., Cain-Hom, C., Choy, L., Hagenbeek, T. J., de Leon, G. P., Chen, Y., Finkle, D., Venook, R., Wu, X., Ridgway, J., et al. (2010) · Nature · doi:10.1038/nature08878 · Cited by 720
The Notch target genes Hey1 and Hey2 are required for embryonic vascular development
Fischer, A., Schumacher, N., Maier, M., Sendtner, M., & Gessler, M. (2004) · Genes & Development · doi:10.1101/gad.291004 · Cited by 655
Mazzieri, R., Pucci, F., Moi, D., Zonari, E., Ranghetti, A., Berti, A., Politi, L. S., Gentner, B., Brown, J. L., Naldini, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.005 · Cited by 639 · cited 1×
“In addition to VEGF, there is increasing evidence that Ang2, via Tie2 expressed on macrophages, plays an important role in their proangiogenic activity, particularly in tumor models.(84) Therefore, macrophages affect angiogenesis in a variety of contexts via distinct signaling pathways.”
BackgroundThe ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients
Joutel, A., Andreux, F., Gaulis, S., Domenga, V., Cecillon, M., Battail, N., Piga, N., Chapon, F., Godfrain, C., & Tournier-Lasserve, E. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8047 · Cited by 602 · cited 1×
“Furthermore, in humans, NOTCH3 is exclusively expressed in arterial vascular smooth muscle cells.(52,58) Mutations in the human NOTCH3 gene are associated with the adult-onset stroke disease, CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), which is caused by cerebr…”
BackgroundGale, N. W., Dominguez, M. G., Noguera, I., Pan, L., Hughes, V., Valenzuela, D. M., Murphy, A. J., Adams, N. C., Lin, H. C., Holash, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407290101 · Cited by 600
Dosage‐sensitive requirement for mouse Dll4 in artery development
Duarte, A., Hirashima, M., Benedito, R., Trindade, A., Diniz, P., Bekman, E., Costa, L., Henrique, D., & Rossant, J. (2004) · Genes & Development · doi:10.1101/gad.1239004 · Cited by 563
Notch3 is required for arterial identity and maturation of vascular smooth muscle cells
Domenga, V., Fardoux, P., Lacombe, P., Monet, M., Maciazek, J., Krebs, L. T., Klonjkowski, B., Berrou, E., Mericskay, M., Li, Z., et al. (2004) · Genes & Development · doi:10.1101/gad.308904 · Cited by 536 · cited 2×
“Notch3 may instead play an important role in the maintenance of mural cell coverage as demonstrated by the fact that Notch3 null mice display enlarged distal arteries with decreased vascular smooth muscle coverage as well as decreased mural cell coverage in the retina later in adulthood.(56,57) In fact, analysis of mu…”
BackgroundLIN-12/Notch signaling: lessons from worms and flies
Greenwald, I. (1998) · Genes & Development · doi:10.1101/gad.12.12.1751 · Cited by 535 · cited 1×
“The Notch signaling pathway functions to modulate cell fate decisions during development and adult life.(1,2) Notch proteins (Notch1, Notch2, Notch3, Notch4) are singlepass transmembrane receptors that interact with 1 of 5 membrane-bound ligands: Jagged1, Jagged2, and Delta-likes Dll1, Dll3, and Dll4.”
BackgroundHaploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants
Krebs, L. T., Shutter, J. R., Tanigaki, K., Honjo, T., Stark, K. L., & Gridley, T. (2004) · Genes & Development · doi:10.1101/gad.1239204 · Cited by 532 · cited 1×
“In contrast, loss of Notch signaling resulted in small-diameter anastamoses between arteries and the anterior cardinal vein in the head of embryos.(20,27) Unexpectedly, the AVMs observed in embryos with endothelial-specific Notch activation phenocopied those of Ephrinb2 nullizygous embryos.”
BackgroundDll4, a novel Notch ligand expressed in arterial endothelium
Shutter, J. R., Scully, S., Fan, W., Richards, W. G., Kitajewski, J., Deblandre, G. A., Kintner, C. R., & Stark, K. L. (2000) · Genes & Development · doi:10.1101/gad.14.11.1313 · Cited by 519
Liu, Z.-J., Shirakawa, T., Li, Y., Soma, A., Oka, M., Dotto, G. P., Fairman, R. M., Velazquez, O. C., & Herlyn, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.14-25.2003 · Cited by 500 · cited 1×
“In vitro Notch has been shown to regulate VEGF receptor expression, whereas VEGF signaling has been shown to induce endothelial Dll4 expression.(46,47) Thus, a model has evolved that connects Notch and VEGF signaling in the regulation of tip/stalk cell identity.”
BackgroundNotch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene
Uyttendaele, H., Marazzi, G., Wu, G., Yan, Q., Sassoon, D., & Kitajewski, J. (1996) · Development · doi:10.1242/dev.122.7.2251 · Cited by 485
DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries
Sörensen, I., Adams, R. H., & Gossler, A. (2009) · Blood · doi:10.1182/blood-2008-08-174508 · Cited by 449
γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
Real, P. J., Tosello, V., Palomero, T., Castillo, M., Hernando, E., de Stanchina, E., Sulis, M. L., Barnes, K., Sawai, C., Homminga, I., et al. (2009) · Nature Medicine · doi:10.1038/nm.1900 · Cited by 445
Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis
Shibuya, M. (2006) · Angiogenesis · doi:10.1007/s10456-006-9055-8 · Cited by 437
Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels
Villa, N., Walker, L., Lindsell, C. E., Gasson, J., Iruela-Arispe, M. L., & Weinmaster, G. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00469-5 · Cited by 429 · cited 6×
“Mural cells express Notch1, Notch2, and Notch3 and the Notch ligands Jagged1 and Dll4.”
BackgroundInfluentialDLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
Hoey, T., Yen, W.-C., Axelrod, F., Basi, J., Donigian, L., Dylla, S., Fitch-Bruhns, M., Lazetic, S., Park, I.-K., Sato, A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.019 · Cited by 398
Davis, R. L., & Turner, D. L. (2001) · Oncogene · doi:10.1038/sj.onc.1205094 · Cited by 389
M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis
Kubota, Y., Takubo, K., Shimizu, T., Ohno, H., Kishi, K., Shibuya, M., Saya, H., & Suda, T. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081605 · Cited by 388 · cited 2×
“As such, macrophage-deficient mice have reduced branching in the retinal vascular plexus.(85,87) Macrophages may also affect the directionality of endothelial cell sprouts by promoting sprouting both forward and sideways to form the vascular plexus.”
BackgroundAcetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase
Guarani, V., Deflorian, G., Franco, C. A., Krüger, M., Phng, L.-K., Bentley, K., Toussaint, L., Dequiedt, F., Mostoslavsky, R., Schmidt, M. H. H., et al. (2011) · Nature · doi:10.1038/nature09917 · Cited by 383 · cited 1×
“Recently, Sirt1 has been shown to inhibit Notch signaling in the stalk cell and thus provide a mechanism by which Notch signaling can be fine-tuned.(49) Sirt1, a deacetylase, was shown to deacytelate the Notch1-ICD to promote its ubiquitinmediated degradation and thereby downregulate Notch-mediated gene transcription.”
BackgroundPotential Role of Microglia in Retinal Blood Vessel Formation
Checchin, D., Sennlaub, F., Levavasseur, E., Leduc, M., & Chemtob, S. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1522 · Cited by 368 · cited 2×
“As such, macrophage-deficient mice have reduced branching in the retinal vascular plexus.(85,87) Macrophages may also affect the directionality of endothelial cell sprouts by promoting sprouting both forward and sideways to form the vascular plexus.”
BackgroundZeng, Q., Li, S., Chepeha, D. B., Giordano, T. J., Li, J., Zhang, H., Polverini, P. J., Nor, J., Kitajewski, J., & Wang, C.-Y. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.004 · Cited by 360
Autiero, M., Luttun, A., Tjwa, M., & Carmeliet, P. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00263.x · Cited by 357
Nrarp Coordinates Endothelial Notch and Wnt Signaling to Control Vessel Density in Angiogenesis
Phng, L.-K., Potente, M., Leslie, J. D., Babbage, J., Nyqvist, D., Lobov, I., Ondr, J. K., Rao, S., Lang, R. A., Thurston, G., et al. (2009) · Developmental Cell · doi:10.1016/j.devcel.2008.12.009 · Cited by 349
Patel, N. S., Li, J.-L., Generali, D., Poulsom, R., Cranston, D. W., & Harris, A. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1208 · Cited by 349 · cited 6×
“Mural cells express Notch1, Notch2, and Notch3 and the Notch ligands Jagged1 and Dll4.”
BackgroundInfluentialHerbert, S. P., Huisken, J., Kim, T. N., Feldman, M. E., Houseman, B. T., Wang, R. A., Shokat, K. M., & Stainier, D. Y. R. (2009) · Science · doi:10.1126/science.1178577 · Cited by 348
High, F. A., Lu, M. M., Pear, W. S., Loomes, K. M., Kaestner, K. H., & Epstein, J. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709663105 · Cited by 321 · cited 1×
“In embryonic and retinal angiogenesis, endothelial Jagged1 deletion resulted in reduced vSMC coverage and vessel dilation.(45,54) In vitro, endothelial JAGGED1 has been shown to signal to NOTCH3 on vSMCs to induce NOTCH3 expression and regulate vSMC differentiation.”
BackgroundVEGFR-1–Selective VEGF Homologue PlGF Is Arteriogenic: Evidence for a Monocyte-Mediated Mechanism
Pipp, F., Heil, M., Issbrücker, K., Ziegelhoeffer, T., Martin, S., van den Heuvel, J., Weich, H., Fernandez, B., Golomb, G., Carmeliet, P., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000057997.77714.72 · Cited by 316
Noseda, M., McLean, G., Niessen, K., Chang, L., Pollet, I., Montpetit, R., Shahidi, R., Dorovini-Zis, K., Li, L., Beckstead, B., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000124300.76171.c9 · Cited by 294
The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth
Thurston, G., Noguera-Troise, I., & Yancopoulos, G. D. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2130 · Cited by 290
Mailhos, C., Modlich, U., Lewis, J., Harris, A., Bicknell, R., & Ish-Horowicz, D. (2001) · Differentiation · doi:10.1046/j.1432-0436.2001.690207.x · Cited by 288
Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium
Uyttendaele, H., Ho, J., Rossant, J., & Kitajewski, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091584598 · Cited by 287
Yochem, J., Weston, K., & Greenwald, I. (1988) · Nature · doi:10.1038/335547a0 · Cited by 287 · cited 1×
“The Notch signaling pathway functions to modulate cell fate decisions during development and adult life.(1,2) Notch proteins (Notch1, Notch2, Notch3, Notch4) are singlepass transmembrane receptors that interact with 1 of 5 membrane-bound ligands: Jagged1, Jagged2, and Delta-likes Dll1, Dll3, and Dll4.”
BackgroundLiu, H., Kennard, S., & Lilly, B. (2009) · Circulation Research · doi:10.1161/circresaha.108.184846 · Cited by 284 · cited 1×
“In vitro, endothelial JAGGED1 has been shown to signal to NOTCH3 on vSMCs to induce NOTCH3 expression and regulate vSMC differentiation.(55) Taken together, these findings demonstrate that Jagged1induced Notch signaling regulates mural cell differentiation.”
BackgroundChronic DLL4 blockade induces vascular neoplasms
Yan, M., Callahan, C. A., Beyer, J. C., Allamneni, K. P., Zhang, G., Ridgway, J. B., Niessen, K., & Plowman, G. D. (2010) · Nature · doi:10.1038/nature08751 · Cited by 280
DeAngelo, D. J., Stone, R. M., Heaney, M. L., Nimer, S. D., Paquette, R. L., Klisovic, R. B., Caligiuri, M. A., Cooper, M. R., Lecerf, J.-M., Karol, M. D., et al. (2006) · Blood · doi:10.1182/blood-2006-02-005702 · Cited by 272 · cited 1×
“However, the GSI-induced toxic effects of goblet cell metaplasia and diarrhea make the reagent unpromising for cancer treatment.(96) Interestingly, Real and colleagues(97) demonstrated that glucocorticoids protected GSI-treated mice from developing goblet cell hyperplasia, which supported the possibility of glucocorti…”
BackgroundIntegrated Regulation of Toll-like Receptor Responses by Notch and Interferon-γ Pathways
Hu, X., Chung, A. Y., Wu, I., Foldi, J., Chen, J., Ji, J. D., Tateya, T., Kang, Y. J., Han, J., Gessler, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.016 · Cited by 263
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions
Noonan, D. M., De Lerma Barbaro, A., Vannini, N., Mortara, L., & Albini, A. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9108-5 · Cited by 253 · cited 1×
“Production of pro-angiogenic factors is generally associated with M2 macrophages, which can produce VEGF, fibroblast growth factor–1 (FGF1), angiopoietin-1 (Ang1), and matrix metalloproteinases.(72,73) However, the inflammatory cytokines, IL-6 and TNFα, that are released by M1 macrophages can also be pro-angiogenic.”
BackgroundAmo, F. F. D., Smith, D. E., Swiatek, P. J., Gendron-Maguire, M., Greenspan, R. J., Mcmahon, A. P., & Gridley, T. (1992) · Development · doi:10.1242/dev.115.3.737 · Cited by 249
Rymo, S. F., Gerhardt, H., Wolfhagen Sand, F., Lang, R., Uv, A., & Betsholtz, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015846 · Cited by 235 · cited 2×
“VEGF-mediated endothelial sprouting and macrophage-mediated anastomosis appear to be distinct steps in angiogenesis.(86,88) In fact, macrophage regulation of vessel fusion is secondary to VEGF-mediated endothelial cell induction, as the number of tip cells and filopodia is comparable in both macrophage-deficient and w…”
BackgroundNakagawa, O., McFadden, D. G., Nakagawa, M., Yanagisawa, H., Hu, T., Srivastava, D., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250485597 · Cited by 230
Harrington, L. S., Sainson, R. C. A., Williams, C. K., Taylor, J. M., Shi, W., Li, J.-L., & Harris, A. L. (2008) · Microvascular Research · doi:10.1016/j.mvr.2007.06.006 · Cited by 215
Mechanistic Insights into Notch Receptor Signaling from Structural and Biochemical Studies
Kovall, R. A., & Blacklow, S. C. (2010) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(10)92002-4 · Cited by 214 · cited 2×
“The Notch intracellular domain (Notch-ICD) is then free to transit to the nucleus, where it forms a transcriptional activating complex with CSL/RBP-J (CBF-1, Suppressor of Hairless, LAG-1) and Mastermind.4 The Notch/CSL transcriptional complex induces the expression of the Hairy/Enhancer of Split (HES) and HES-related…”
BackgroundNotch1 and Notch2 Inhibit Myeloid Differentiation in Response to Different Cytokines
Bigas, A., Martin, D. I. K., & Milner, L. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2324 · Cited by 211 · cited 1×
“Until recently, studies of Notch signaling in the myeloid lineage have focused on differentiation of progenitor cells.(67,68) However, Notch signaling can also be activated in monocytes and macrophages, suggesting a role for Notch in mature cells of the myeloid lineage.”
BackgroundCarlson, T. R., Yan, Y., Wu, X., Lam, M. T., Tang, G. L., Beverly, L. J., Messina, L. M., Capobianco, A. J., Werb, Z., & Wang, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504391102 · Cited by 200
Taylor, K. L., Henderson, A. M., & Hughes, C. C. W. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2443 · Cited by 199
Jin, S., Hansson, E. M., Tikka, S., Lanner, F., Sahlgren, C., Farnebo, F., Baumann, M., Kalimo, H., & Lendahl, U. (2008) · Circulation Research · doi:10.1161/circresaha.107.167965 · Cited by 198
Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma
Huang, S.-P., Wu, M.-S., Shun, C.-T., Wang, H.-P., Lin, M.-T., Kuo, M.-L., & Lin, J.-T. (2004) · Journal of Biomedical Science · doi:10.1007/bf02256101 · Cited by 190 · cited 1×
“However, the inflammatory cytokines, IL-6 and TNFα, that are released by M1 macrophages can also be pro-angiogenic.(74,75) Thus, stimulation of angiogenesis is a function of macrophages that is not necessarily limited to a particular differentiation state.”
BackgroundNotch3 Is Critical for Proper Angiogenesis and Mural Cell Investment
Liu, H., Zhang, W., Kennard, S., Caldwell, R. B., & Lilly, B. (2010) · Circulation Research · doi:10.1161/circresaha.110.218271 · Cited by 187 · cited 2×
“Despite being viable and fertile, adult Notch3 nullizygous mice present with altered vascular mural cell coverage.(56) However, earlier in development, mural cell coverage is normal in the retinas of Notch3 mice, suggesting that Notch3 does not contribute to mural cell recruitment.”
BackgroundAngiogenesis and inflammation face off
Imhof, B. A., & Aurrand-Lions, M. (2006) · Nature Medicine · doi:10.1038/nm0206-171 · Cited by 180 · cited 1×
“There may not be a need for a distinction between inflammatory and angiogenic tissue, as inflammation occurs in vascularized tissue, and conversely, inflammation necessitates remodeling of blood vessels that are often damaged or destroyed by the inflammatory process.(90) Wounds, tumors, and many other pathological pro…”
BackgroundMyeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation
Schmid, M. C., & Varner, J. A. (2010) · Journal of Oncology · doi:10.1155/2010/201026 · Cited by 180
Macrophage Activation: Classical Vs. Alternative
Classen, A., Lloberas, J., & Celada, A. (2009) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-396-7_3 · Cited by 174
Monsalve, E., Pérez, M. A., Rubio, A., Ruiz-Hidalgo, M. J., Baladrón, V., García-Ramírez, J. J., Gómez, J. C., Laborda, J., & Díaz-Guerra, M. J. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5362 · Cited by 174
Smooth Muscle α-Actin Is a Direct Target of Notch/CSL
Noseda, M., Fu, Y., Niessen, K., Wong, F., Chang, L., McLean, G., & Karsan, A. (2006) · Circulation Research · doi:10.1161/01.res.0000229683.81357.26 · Cited by 174
Modulation of VEGF signalling output by the Notch pathway
Siekmann, A. F., Covassin, L., & Lawson, N. D. (2008) · BioEssays · doi:10.1002/bies.20736 · Cited by 173
Notch signaling contributes to the pathogenesis of human osteosarcomas
Engin, F., Bertin, T., Ma, O., Jiang, M. M., Wang, L., Sutton, R. E., Donehower, L. A., & Lee, B. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp057 · Cited by 168
Shawber, C. J., Funahashi, Y., Francisco, E., Vorontchikhina, M., Kitamura, Y., Stowell, S. A., Borisenko, V., Feirt, N., Podgrabinska, S., Shiraishi, K., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci24311 · Cited by 166 · cited 4×
“Knockout studies have shown that approximately half of the Notch1;Vegfr-3 double heterozygous mouse embryos die in utero due to angiogenic defects and display reduced Vegfr-3 expression in the blood vasculature.(32) However, the positive regulation of VEGFR-3 by Notch is context dependent since Notch has been shown to…”
BackgroundNotch1 upregulates LPS‐induced macrophage activation by increasing NF‐κB activity
Monsalve, E., Ruiz‐García, A., Baladrón, V., Ruiz‐Hidalgo, M. J., Sánchez‐Solana, B., Rivero, S., García‐Ramírez, J. J., Rubio, A., Laborda, J., & Díaz‐Guerra, M. J. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200838722 · Cited by 152
A Notch1 Ectodomain Construct Inhibits Endothelial Notch Signaling, Tumor Growth, and Angiogenesis
Funahashi, Y., Hernandez, S. L., Das, I., Ahn, A., Huang, J., Vorontchikhina, M., Sharma, A., Kanamaru, E., Borisenko, V., DeSilva, D. M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6499 · Cited by 151
Notch Ligand Delta-Like 1 Is Essential for Postnatal Arteriogenesis
Limbourg, A., Ploom, M., Elligsen, D., Sörensen, I., Ziegelhoeffer, T., Gossler, A., Drexler, H., & Limbourg, F. P. (2007) · Circulation Research · doi:10.1161/01.res.0000258174.77370.2c · Cited by 151 · cited 2×
“Furthermore, ischemia-induced arteriogenesis was severely impaired in Dll1 heterozygous mice and correlated with a loss of EphrinB2 expression.(24) Throughout vascular development, it appears that Notch may act both in concert and independent of EphrinB2.”
BackgroundTrindade, A., Kumar, S. R., Scehnet, J. S., Lopes-da-Costa, L., Becker, J. D., Jiang, W., Liu, R., Gill, P. S., & Duarte, A. (2008) · Blood · doi:10.1182/blood-2007-09-112748 · Cited by 148 · cited 1×
“Similarly, endothelial-specific overexpression of Dll4 correlates with a loss of venous endothelial EphB4 expression and a gain in arterial endothelial EphrinB2 in the cardinal vein.(36) In contrast, disruption of Dll4/Notch1 signaling had the opposite phenotype, observed as an increase in EphB4+ endothelial cells in…”
BackgroundArtery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis
Kim, Y. H., Hu, H., Guevara-Gallardo, S., Lam, M. T. Y., Fong, S.-Y., & Wang, R. A. (2008) · Development · doi:10.1242/dev.022475 · Cited by 148 · cited 2×
“In contrast, disruption of Dll4/Notch1 signaling had the opposite phenotype, observed as an increase in EphB4+ endothelial cells in the cardinal vein and reduced EphrinB2+ endothelial cells in the dorsal aorta.(33,41) Taken together, these data suggest that activation of Notch promotes endothelial cell differentiation…”
BackgroundZimrin, A. B., Pepper, M. S., McMahon, G. A., Nguyen, F., Montesano, R., & Maciag, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32499 · Cited by 146 · cited 3×
“Subsequently, it came to be appreciated that endothelial cells also express the Notch ligands, Dll1,10 Dll4,11,12 and Jagged1.”
BackgroundInfluentialCampos, A. H., Wang, W., Pollman, M. J., & Gibbons, G. H. (2002) · Circulation Research · doi:10.1161/01.res.0000044944.99984.25 · Cited by 144 · cited 1×
“Interestingly, exposure to exogenous homodimeric PDGF-BB has been shown to downregulate NOTCH3 expression in vascular smooth muscle cells, again suggesting that NOTCH3 is not required for mural cell recruitment.(63) Thus, one can propose a model whereby Notch1 signaling is critical for mural cell recruitment to new ve…”
BackgroundOuttz, H. H., Tattersall, I. W., Kofler, N. M., Steinbach, N., & Kitajewski, J. (2011) · Blood · doi:10.1182/blood-2010-12-327015 · Cited by 142 · cited 1×
“Notch signaling was shown to regulate macrophage recruitment and macrophage activity in vessel anastomosis during angiogenesis.(89) Specifically, Notch1 was shown to be critical for macrophage recruitment to sites of active angiogenesis, as demonstrated by a loss of macrophage localization to the vascular front in mic…”
BackgroundMurakami, M., Zheng, Y., Hirashima, M., Suda, T., Morita, Y., Ooehara, J., Ema, H., Fong, G.-H., & Shibuya, M. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.150433 · Cited by 142
Foldi, J., Chung, A. Y., Xu, H., Zhu, J., Outtz, H. H., Kitajewski, J., Li, Y., Hu, X., & Ivashkiv, L. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001544 · Cited by 128
Hamilton Outtz, H., Wu, J. K., Wang, X., & Kitajewski, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000720 · Cited by 125
Notch1 loss of heterozygosity causes vascular tumors and lethal hemorrhage in mice
Liu, Z., Turkoz, A., Jackson, E. N., Corbo, J. C., Engelbach, J. A., Garbow, J. R., Piwnica-Worms, D. R., & Kopan, R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43114 · Cited by 119
Notch expression patterns in the retina: An eye on receptor–ligand distribution during angiogenesis
Hofmann, J. J., & Iruela‐Arispe, M. L. (2006) · Gene Expression Patterns · doi:10.1016/j.modgep.2006.11.002 · Cited by 116 · cited 5×
“Mural cells express Notch1, Notch2, and Notch3 and the Notch ligands Jagged1 and Dll4.”
BackgroundInfluentialNotch regulates the angiogenic response via induction of VEGFR-1
Funahashi, Y., Shawber, C. J., Vorontchikhina, M., Sharma, A., Outtz, H. H., & Kitajewski, J. (2010) · Vascular Cell · doi:10.1186/2040-2384-2-3 · Cited by 110
Notch Signaling Induces Multilineage Myeloid Differentiation and Up-Regulates PU.1 Expression
Schroeder, T., Kohlhof, H., Rieber, N., & Just, U. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5538 · Cited by 109 · cited 1×
“Until recently, studies of Notch signaling in the myeloid lineage have focused on differentiation of progenitor cells.(67,68) However, Notch signaling can also be activated in monocytes and macrophages, suggesting a role for Notch in mature cells of the myeloid lineage.”
Background1. Sorafenib in advanced clear-cell renal-cell carcinoma
Trump, D. L. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.08.008 · Cited by 109
Expression of notch receptors, notch ligands, and fringe genes in hematopoiesis
Singh, N., Phillips, R. A., Iscove, N. N., & Egan, S. E. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00146-6 · Cited by 109
Krebs, L. T., Starling, C., Chervonsky, A. V., & Gridley, T. (2010) · genesis · doi:10.1002/dvg.20599 · Cited by 106
Kodera, Y., Katanasaka, Y., Kitamura, Y., Tsuda, H., Nishio, K., Tamura, T., & Koizumi, F. (2011) · Breast Cancer Research · doi:10.1186/bcr2903 · Cited by 106
Dll4-selective Notch signaling induces ephrinB2 gene expression in endothelial cells
Iso, T., Maeno, T., Oike, Y., Yamazaki, M., Doi, H., Arai, M., & Kurabayashi, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.020 · Cited by 99
Notch Signaling in Primary Endothelial Cells
SHAWBER, C. J., DAS, I., FRANCISCO, E., & KITAJEWSKI, J. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03219.x · Cited by 98 · cited 5×
“The Notch/CSL transcriptional complex induces the expression of the Hairy/Enhancer of Split (HES) and HES-related genes (HEY, CHF, HRT, HESR).(5) The HES and HEY genes encode basic-helix-loop-helix transcriptional repressors that serve as important Notch signaling effectors.”
BackgroundExpression of the mouse Delta1 gene during organogenesis and fetal development
Beckers, J., Clark, A., Wünsch, K., de Angelis, M. H., & Gossler, A. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00065-9 · Cited by 82
Bare rudiments of notch signaling: how receptor levels are regulated
Wu, J., & Bresnick, E. H. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.09.002 · Cited by 61 · cited 1×
“The many combinations of Notch ligands and receptors and the spatial and temporal regulation of Notch ligand and receptor expression can mediate differences in Notch signaling activity depending on context.(92)”
BackgroundStewart, K. S., Zhou, Z., Zweidler-McKay, P., & Kleinerman, E. S. (2011) · Blood · doi:10.1182/blood-2010-05-284869 · Cited by 41 · cited 1×
“In fact, Dll4 signaling has been shown to be required by bone marrow–derived cells to activate expression of pericyte/vascular smooth muscle–specific cell markers.(66) Expression of the intracellular domain of Notch1 in cultured endothelial cells was shown to induce morphological and functional changes that were chara…”
BackgroundKalén, M., Heikura, T., Karvinen, H., Nitzsche, A., Weber, H., Esser, N., Ylä‐Herttuala, S., & Hellström, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018709 · Cited by 41
Yamashiro, K. (1992) · International Journal of Oncology · doi:10.3892/ijo_00000163 · Cited by 27
Interleukin-6 Increases Vascular Endothelial Growth Factor and Angiogenesis in Gastric Carcinoma
Huang, S., Wu, M., Shun, C., et al. (2004) · Journal of Biomedical Science · doi:10.1159/000077902 · Cited by 25
sFLT01: A Novel Fusion Protein with Antiangiogenic Activity
Bagley, R. G., Kurtzberg, L. S., Weber, W. D., Nguyen, T., Roth, S., Krumbholz, R. D., Yao, M., Richards, B., Zhang, M., Pechan, P. A., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0813 · Cited by 24
M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis
Kubota, Y., Takubo, K., Shimizu, T., Ohno, H., Kishi, K., Shibuya, M., Saya, H., & Suda, T. (2009) · The Journal of Cell Biology · doi:10.1083/jcb1853oia6 · Cited by 21
Research works printed but not linked: 2
- [39]39. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol. 1995;11:73-91 [DOI] [PubMed] [Google Scholar]
- [128]128. Sawyer TK. AILERON Therapeutics. Chem Biol Drug Des. 2009;73(1):3-6 [DOI] [PubMed] [Google Scholar]
Cited by
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
Schaaf, M. B., Garg, A. D., & Agostinis, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0061-0 · Cited by 629
Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
Gianferante, D. M., Mirabello, L., & Savage, S. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.16 · Cited by 477
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
“Notch signaling plays a key role in determining cell fate and regulating embryonic as well as tumor angiogenesis [132, 133].”
BackgroundYoo, S.-K., Song, Y. S., Lee, E. K., Hwang, J., Kim, H. H., Jung, G., Kim, Y. A., Kim, S.-J., Cho, S. W., Won, J.-K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10680-5 · Cited by 268
Pericytes are progenitors for coronary artery smooth muscle
Volz, K. S., Jacobs, A. H., Chen, H. I., Poduri, A., McKay, A. S., Riordan, D. P., Kofler, N., Kitajewski, J., Weissman, I., & Red-Horse, K. (2015) · eLife · doi:10.7554/elife.10036 · Cited by 226
“NG2 and Notch3 are well-established pericyte markers in other tissues (Armulik et al., 2011; Kofler et al., 2011).”
Background
Metadata
- Authors
- Kofler, N. M., Shawber, C. J., Kangsamaksin, T., Reed, H. O., Galatioto, J., & Kitajewski, J.
- Affiliations
- Columbia University Irving Medical Center (US)
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2011-10-06
- Volume
- 2
- Issue
- 12
- Pages
- 1106-1116
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- PMC
- PMC3411124
- OpenAlex
- W2140676103
- Cited by
- 142
- References
- 129
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 12 · 2023: 9 · 2022: 13 · 2021: 7 · 2020: 7 · 2019: 17 · 2018: 18 · 2017: 12 · 2016: 8 · 2015: 8 · 2014: 11 · 2013: 9
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Genes & Cancer (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL062454, F31HL090032)
- National Cancer Institute (R01CA136673)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007328)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- Notch signaling, angiogenesis, tumor angiogenesis, vascular development, arterial specification, sprouting angiogenesis, vessel maturation, vascular mural cells, macrophages, tumor vasculature, Notch inhibitors, tumor growth inhibition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.